The transcriptional response of cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host

Eukaryotic Cell

Volumn 12, Issue 5, 2013, Pages 761-774

  Derengowski, Lorena da S ^a,b   Paes, Hugo Costa ^a   Albuquerque, Patrícia ^a,b   Tavares, Aldo Henrique F P ^a   Fernandes, Larissa ^a   Silva Pereira, Ildinete ^a   Casadevall, Arturo ^b  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTOME;

ACANTHAMOEBA CASTELLANII; ADAPTATION; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DNA MICROARRAY; FEMALE; FUNGAL GENE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; KINETICS; LARVA; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOTH; MOUSE; PATHOGENICITY; PHAGOCYTOSIS; PHENOTYPE; SPECIES DIFFERENCE; VIRULENCE;

ACANTHAMOEBA CASTELLANII; ADAPTATION, BIOLOGICAL; ANIMALS; CELL LINE; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FEMALE; GENE EXPRESSION REGULATION, FUNGAL; GENES, FUNGAL; HOST-PATHOGEN INTERACTIONS; KINETICS; LARVA; MACROPHAGES; MICE; MICE, INBRED BALB C; MOTHS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; PHENOTYPE; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC; TRANSCRIPTOME; VIRULENCE;

ACANTHAMOEBA CASTELLANII; FILOBASIDIELLA NEOFORMANS; FUNGI; LEPIDOPTERA; MAMMALIA; MURINAE; MUS; PROTOZOA;

EID: 84876835512     PISSN: 15359778     EISSN: None     Source Type: Journal    
DOI: 10.1128/EC.00073-13     Document Type: Article

References (62)

1. Ellis DH, Pfeiffer TJ. 1990. Ecology, life cycle, and infectious propagule of Cryptococcus neoformans. Lancet 336:923-925.
2. Hogan LH, Klein BS, Levitz SM. 1996. Virulence factors of medically important fungi. Clin. Microbiol. Rev. 9:469-488.
3. Alanio A, Desnos-Ollivier M, Dromer F. 9 August 2011. Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. mBio 2(4):e00158-11. doi:10.1128/mBio.00158-11.
4. Fan W, Kraus PR, Boily MJ, Heitman J. 2005. Cryptococcus neoformans gene expression during murine macrophage infection. Eukaryot. Cell 4:1420-1433.
5. Levitz SM, Nong SH, Seetoo KF, Harrison TS, Speizer RA, Simons ER. 1999. Cryptococcus neoformans resides in an acidic phagolysosome of human macrophages. Infect. Immun. 67:885-890.
6. Feldmesser M, Kress Y, Novikoff P, Casadevall A. 2000. Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection. Infect. Immun. 68:4225-4237.
7. Casadevall A, Perfect JR. 1998 Cryptococcus neoformans: molecular pathogenesis and clinical management. ASM Press, Washington, DC.
8. Feldmesser M, Tucker S, Casadevall A. 2001. Intracellular parasitism of macrophages by Cryptococcus neoformans. Trends Microbiol. 9:273-278.
9. Amer AO, Swanson MS. 2002. A phagosome of one's own: a microbial guide to life in the macrophage. Curr. Opin. Microbiol. 5:56-61.
10. Lorenz MC, Fink GR. 2002. Life and death in a macrophage: role of the glyoxylate cycle in virulence. Eukaryot. Cell 1:657-662.
11. Romanini L. 2004. Immunity to fungal infections. Nat. Rev. Immunol. 4:1-23.
12. Steenbergen JN, Shuman HA, Casadevall A. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. U. S. A. 98:15245-15250.
13. Steenbergen JN, Casadevall A. 2003. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 5:667-675.
14. Casadevall A, Steenbergen JN, Nosanchuk JD. 2003. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi-the Cryptococcus neoformans paradigm. Curr. Opin. Microbiol. 6:332-337.
15. Steenbergen JN, Nosanchuk JD, Malliaris SD, Casadevall A. 2003. Cryptococcus neoformans virulence is enhanced after growth in the genetically malleable host Dictyostelium discoideum. Infect. Immun. 71:4862-4872.
16. Liu OW, Chun CD, Chow ED, Chen C, Madhani HD, Noble SM. 2008. Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans. Cell 135:174-188.
17. -ΔΔCT method. Methods 25: 402-408.
18. Kim MS, Kim SY, Yoon JK, Lee YW, Bahn YS. 2009. An efficient gene-disruption method in Cryptococcus neoformans by double-joint PCR with NAT-split markers. Biochem. Biophys. Res. Commun. 390:983-988.
19. Toffaletti DL, Rude TH, Johnston SA, Durack DT, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175:1405-1411.
20. Nielsen K, Cox GM, Litvintseva AP, Mylonakis E, Malliaris SD, Benjamin DK, Jr, Giles SS, Mitchell TG, Casadevall A, Perfect JR, Heitman J. 2005. Cryptococcus neoformans α strains preferentially disseminate to the central nervous system during coinfection. Infect. Immun. 73:4922-4933.
21. Chen SC, Wright LC, Santangelo RT, Muller M, Moran VR, Kuchel PW, Sorrell TC. 1997. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect. Immun. 65:405-411.
22. Niehaus WG, Flynn T. 1994. Regulation of mannitol biosynthesis and degradation by Cryptococcus neoformans. J. Bacteriol. 176:651-655.
23. Feldmesser M, Casadevall A. 1997. Effect of serum IgG1 to Cryptococcus neoformans glucuronoxylomannan on murine pulmonary infection. J. Immunol. 158:790-799.
24. García-Rodas R, Casadevall A, Rodríguez-Tudela JL, Cuenca-Estrella M, Zaragoza O. 2011. Cryptococcus neoformans capsular enlargement and cellular gigantism during Galleria mellonella infection. PLoS One 6:e24485. doi:10.1371/journal.pone.0024485.
25. Ma H, Croudace JE, Lammas DA, May RC. 2006. Expulsion of live pathogenic yeast by macrophages. Curr. Biol. 16:2156-2160.
26. Alvarez M, Casadevall A. 2006. Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages. Curr. Biol. 16:2161-2165.
27. Zaragoza O, Chrisman CJ, Castelli MV, Frases S, Cuenca-Estrella M, Rodríguez-Tudela JL, Casadevall A. 2008. Capsule enlargement in Cryptococcus neoformans confers resistance to oxidative stress suggesting a mechanism for intracellular survival. Cell. Microbiol. 10:2043-2057.
28. Casadevall A. 2012. Amoeba provides insight into the origin of virulence in pathogenic fungi. Adv. Exp. Med. Biol. 710:1-10.
29. Bunting LA, Neilson JB, Bulmer GS. 1979. Cryptococcus neoformans: gastronomic delight of a soil ameba. Sabouraudia 17:225-232.
30. Ruiz A, Neilson JB, Bulmer GS. 1982. Control of Cryptococcus neoformans in nature by biotic factors. Sabouraudia 20:21-29.
31. Chrisman CJ, Albuquerque P, Guimaraes AJ, Nieves E, Casadevall A. 2011. Phospholipids trigger Cryptococcus neoformans capsular enlargement during interactions with amoebae and macrophages. PLoS Pathog. 7:e1002047. doi:10.1371/journal.ppat.1002047.
32. Rahme LG, Tan MW, Le L, Wong SM, Tompkins RG, Calderwood SB, Ausubel FM. 1997. Use of model plant hosts to identify Pseudomonas aeruginosa virulence factors. Proc. Natl. Acad. Sci. U. S. A. 94:13245-13250.
33. Lorenz MC, Fink GR. 2001. The glyoxylate cycle is required for fungal virulence. Nature 412:83-86.
34. Schnappinger D, Ehrt S, Voskuil MI, Liu Y, Mangan JA, Monahan IM, Dolganov G, Efron B, Butcher PD, Nathan C, Schoolnik GK. 2003. Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment. J. Exp. Med. 198:693-704.
35. Lorenz MC, Bender JA, Fink GR. 2004. Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot. Cell 3:1076-1087.
36. Tavares AH, Silva SS, Dantas A, Campos EG, Andrade RV, Maranhão AQ, Brígido MM, Passos-Silva DG, Fachin AL, Teixeira SM, Passos GA, Soares CM, Bocca AL, Carvalho MJ, Silva-Pereira I, Felipe MS. 2007. Early transcriptional response of Paracoccidioides brasiliensis upon internalization by murine macrophages. Microbes Infect. 9:583-590.
37. Hu G, Cheng PY, Sham A, Perfect JR, Kronstad JW. 2008. Metabolic adaptation in Cryptococcus neoformans during early murine pulmonary infection. Mol. Microbiol. 69:1456-1475.
38. Onishi H, Suzuki T. 1968. Production of D-mannitol and glycerol by yeasts. Appl. Microbiol. 16:1847-1852.
39. Wong B, Perfect JR, Beggs S, Wright KA. 1990. Production of the hexitol D-mannitol by Cryptococcus neoformans in vitro and in rabbits with experimental meningitis. Infect. Immun. 58:1664-1670.
40. Chaturvedi V, Flynn T, Niehaus WG, Wong B. 1996. Stress tolerance and pathogenic potential of a mannitol mutant of Cryptococcus neoformans. Microbiology 142:937-943.
41. Guimarães AJ, Frases S, Cordero RJ, Nimrichter L, Casadevall A, Nosanchuk JD. 2010. Cryptococcus neoformans responds to mannitol by increasing capsule size in vitro and in vivo. Cell. Microbiol. 12:740-753.
42. Panepinto J, Liu L, Ramos J, Zhu X, Valyi-Nagy T, Eksi S, Fu J, Jaffe HA, Wickes B, Williamson PR. 2005. The DEAD-box RNA helicase Vad1 regulates multiple virulence associated genes in Cryptococcus neoformans. J. Clin. Invest. 115:632-641.
43. Derengowski LS, Tavares AH, Silva S, Procópio LS, Felipe MS, Silva-Pereira I. 2008. Upregulation of glyoxylate cycle genes upon Paracoccidioides brasiliensis internalization by murine macrophages and in vitro nutritional stress condition. Med. Mycol. 46:125-134.
44. Giles SS, Stajich JE, Nichols C, Gerrald QD, Alspaugh JA, Dietrich F, Perfect JR. 2006. The Cryptococcus neoformans catalase gene family and its role in antioxidant defense. Eukaryot. Cell 5:1447-1459.
45. Giles SS, Perfect JR, Cox GM. 2005. Cytochrome c peroxidase contributes to the antioxidant defense of Cryptococcus neoformans. Fungal Genet. Biol. 42:20-29.
46. Missall TA, Lodge JK. 2005. Thioredoxin reductase is essential for viability in the fungal pathogen Cryptococcus neoformans. Eukaryot. Cell 4:487-489.
47. Dagsgaard C, Taylor LE, O'Brien KM, Poyton RO. 2001. Effects of anoxia and the mitochondrion on expression of aerobic nuclear COX genes in yeast: evidence for a signaling pathway from the mitochondrial genome to the nucleus. J. Biol. Chem. 276:7593-7601.
48. Toffaletti DL, Del Poeta M, Rude TH, Dietrich F, Perfect JR. 2003. Regulation of cytochrome c oxidase subunit 1 (COX1) expression in Cryptococcus neoformans by temperature and host environment. Microbiology 149:1041-1049.
49. Li AH, Lam WL, Stokes RW. 2008. Characterization of genes differentially expressed within macrophages by virulent and attenuated Mycobacterium tuberculosis identifies candidate genes involved in intracellular growth. Microbiology 154:2291-2303.
50. Gillespie J, Barton LL, Rypka EW. 1988. Influence of oxygen tension on the respiratory activity of Mycobacterium phlei. J. Gen. Microbiol. 134: 247-252.
51. Gancedo C, Flores CL. 2004. The importance of a functional trehalose biosynthetic pathway for the life of yeasts and fungi. FEMS Yeast Res. 4:351-359.
52. Zaragoza O, de Virgilio C, Pontón J, Gancedo C. 2002. Disruption in Candida albicans of the TPS2 gene encoding trehalose-6-phosphate phosphatase affects cell integrity and decreases infectivity. Microbiology 148: 1281-1290.
53. Petzold EW, Himmelreich U, Mylonakis E, Rude T, Toffaletti D, Cox GM, Miller JL, Perfect JR. 2006. Characterization and regulation of the trehalose synthesis pathway and its importance in the pathogenicity of Cryptococcus neoformans. Infect. Immun. 74:5877-5887.
54. Kraus PR, Boily MJ, Giles SS, Stajich JE, Allen A, Cox GM, Dietrich FS, Perfect JR, Heitman J. 2004. Identification of Cryptococcus neoformans temperature-regulated genes with a genomic-DNA microarray. Eukaryot. Cell 3:1249-1260.
55. Hottiger T, Boller T, Wiemken A. 1987. Rapid changes of heat and desiccation tolerance correlated with changes of trehalose content in Saccharomyces cerevisiae cells subjected to temperature shifts. FEBS Lett. 220: 113-115.
56. Chen Q, Haddad GG. 2004. Role of trehalose phosphate synthase and trehalose during hypoxia: from flies to mammals. J. Exp. Biol. 207:3125-3129.
57. Rosenfeld E, Beauvoit B. 2003. Role of the non-respiratory pathways in the utilization of molecular oxygen by Saccharomyces cerevisiae. Yeast 20: 1115-1144.
58. Shobayashi M, Mitsueda S, Ago M, Fujii T, Iwashita K, Iefuji H. 2005. Effects of culture conditions on ergosterol biosynthesis by Saccharomyces cerevisiae. Biosci. Biotechnol. Biochem. 69:2381-2388.
59. Shea JM, Kechichian TB, Luberto C, Del Poeta M. 2006. The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect. Immun. 74:5977-5988.
60. Wilder JA, Olson GK, Chang YC, Kwon-Chung KJ, Lipscomb MF. 2002. Complementation of a capsule deficient Cryptococcus neoformans with CAP64 restores virulence in a murine lung infection. Am. J. Respir. Cell Mol. Biol. 26:306-314.
61. Chang YC, Penoyer LA, Kwon-Chung KJ. 1996. The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64:1977-1983.
62. Rittershaus PC, Kechichian TB, Allegood JC, Merrill AH, Jr, Hennig M, Luberto C, Del Poeta M. 2006. Glucosylceramide synthase is an essential regulator of pathogenicity of Cryptococcus neoformans. J. Clin. Invest. 116: 1651-1659.